For instance, the Immunoscore is a method for (semi-) quantification of CD3+ and CD8+ infiltrating T cells introduced in renal cell carcinoma and colorectal cancer but has not been utilized in SCCHN as a potential diagnostic or prognostic biomarker [54,75,76,77,78]. This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.